New sepsis treatment draws skepticism

One doctor’s claims of having a new and effective treatment for sepsis may be true, NPR reports, but he needs better clinical evidence to prove it.

Sepsis kills about 300,000 people a year, making it the leading cause of death in hospitals. So it would make a big difference if others can replicate the results of Paul Marik, MD, an intensive care physician at the Eastern Virginia Medical Center in Norfolk. He said using a mix of intravenous corticosteroids, vitamin C and vitamin B, along with careful management of fluids, he treated 150 sepsis patients and had only one die of the condition.

But his results don’t come from a randomized trial run at multiple hospitals, and doing such an experiment may take up to two years, leaving the medical world skeptical of Marik’s promises in the meantime.

“Nothing has worked despite all the great ideas people have had, often ballyhooed with observational data like this, claiming that it's a big effect,” said former Food and Drug Administration Commissioner Robert Califf, MD.

Other doctors, however, are already planning on using Marik’s techniques, even without more robust clinical evidence.

Read the full article below: 

""
John Gregory, Senior Writer

John joined TriMed in 2016, focusing on healthcare policy and regulation. After graduating from Columbia College Chicago, he worked at FM News Chicago and Rivet News Radio, and worked on the state government and politics beat for the Illinois Radio Network. Outside of work, you may find him adding to his never-ending graphic novel collection.

Around the web

Compensation for heart specialists continues to climb. What does this say about cardiology as a whole? Could private equity's rising influence bring about change? We spoke to MedAxiom CEO Jerry Blackwell, MD, MBA, a veteran cardiologist himself, to learn more.

The American College of Cardiology has shared its perspective on new CMS payment policies, highlighting revenue concerns while providing key details for cardiologists and other cardiology professionals. 

As debate simmers over how best to regulate AI, experts continue to offer guidance on where to start, how to proceed and what to emphasize. A new resource models its recommendations on what its authors call the “SETO Loop.”